Clearside Biomedical's Versatile Suprachoroidal Injection Pl

ALPHARETTA, Ga., Nov. 07, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,...

Related Keywords

United States , American , George Lasezkay , Jenny Kobin , Triamcinolone Acetonide Suprachoroidal , Remy Bernarda , Belzupacap Sarotalocan , Markr Barakat , Rahuln Khurana , American Academy Of Ophthalmology , Suprachoroidal Administration , Late Breaker Development , Globenewswire Inc , Nasdaq , Clearside Biomedical Inc , Linkedin , Exchange Commission , Annual Meeting , Chief Executive , Aura Biosciences , Special Protocol Assessment , Axitinib Injectable Suspension , Extension Study , Suprachoroidal Delivery , Gene Therapy , Diabetic Retinopathy Severity Scale , Targeted Investigational Therapy , Choroidal Melanoma , Uveitic Macular Edema , Suprachoroidal Space , Injection Platform , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Periodic Reports , Media Contacts , Markets ,